Progress report on new antiepileptic drugs: A summary of the Sixteenth Eilat Conference on New Antiepileptic Drugs and Devices (EILAT XVI): II. Drugs in more advanced clinical development

Affiliations

• 1 Institute for Drug Research, Faculty of Medicine, School of Pharmacy, and David R. Bloom Center for Pharmacy, Hebrew University of Jerusalem, Jerusalem, Israel.
• 2 National Center for Epilepsy, Sandvika, Norway.
• 3 Department of Pharmacology, Oslo University Hospital, Oslo, Norway.
• 4 Department of Clinical and Experimental Epilepsy, University College London Queen Square Institute of Neurology, London, UK.
• 5 Department of Pharmaceutics and Neurological Surgery, University of Washington, Seattle, Washington, USA.
• 6 Department of Medicine (Austin Health), University of Melbourne, Melbourne, Victoria, Australia.
• 7 Department of Neuroscience, Central Clinical School, Monash University, Melbourne, Victoria, Australia.
• 8 Bladin-Berkovic Comprehensive Epilepsy Program, Department of Neurology, Austin Health, Melbourne, Victoria, Australia.
• 9 Department of Neurology, The Royal Melbourne Hospital, Melbourne, Victoria, Australia.
• 10 Department of Neurology, Alfred Health, Melbourne, Victoria, Australia.
• 11 Department of Clinical Neuroscience, Karolinska Institute, Stockholm, Sweden.
• 12 Department of Pharmacy, School of Pharmacy, University of Washington, Seattle, Washington, USA.